Rajthanee Hospital PCL (BKK:RJH)
Thailand · Delayed Price · Currency is THB 15.00
+0.20 (1.35%)
Sep 3, 2026, 12:28 PM ICT
Rajthanee Hospital PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,928 | 2,741 | 2,739 | 2,348 | 3,365 | 3,118 |
Other Revenue | 28.46 | 28.9 | 26.09 | 27.54 | 26.15 | 24.28 |
| 2,956 | 2,770 | 2,765 | 2,375 | 3,392 | 3,142 | |
Revenue Growth | 6.99% | 0.20% | 16.39% | -29.96% | 7.94% | 67.35% |
Cost of Revenue | 2,167 | 2,073 | 1,897 | 1,618 | 1,848 | 1,684 |
Gross Profit | 789.38 | 697.56 | 867.42 | 757.68 | 1,544 | 1,458 |
Selling, General & Admin | 382.97 | 317.26 | 345.18 | 222.43 | 244.95 | 183.46 |
Operating Expenses | 382.97 | 317.26 | 345.18 | 222.43 | 244.95 | 183.46 |
Operating Income | 406.42 | 380.3 | 522.25 | 535.25 | 1,299 | 1,274 |
Interest Expense | -52.05 | -57.7 | -52.67 | -33.54 | -24.48 | -5.92 |
Interest & Investment Income | 4.35 | 2.95 | 10.89 | 17.24 | 15.04 | 2.81 |
EBT Excluding Unusual Items | 358.72 | 325.55 | 480.47 | 518.94 | 1,289 | 1,271 |
Pretax Income | 358.72 | 325.55 | 480.47 | 518.94 | 1,289 | 1,271 |
Income Tax Expense | -13.96 | 39.18 | -1.95 | 103.24 | 255.8 | 254.92 |
Earnings From Continuing Operations | 372.67 | 286.37 | 482.42 | 415.7 | 1,034 | 1,016 |
Minority Interest in Earnings | -0.52 | 8.77 | 10.62 | 3.97 | -4.45 | -4.36 |
Net Income | 372.15 | 295.14 | 493.04 | 419.67 | 1,029 | 1,012 |
Net Income to Common | 372.15 | 295.14 | 493.04 | 419.67 | 1,029 | 1,012 |
Net Income Growth | -3.22% | -40.14% | 17.48% | -59.22% | 1.71% | 145.33% |
Shares Outstanding (Basic) | 293 | 293 | 299 | 299 | 299 | 300 |
Shares Outstanding (Diluted) | 293 | 293 | 299 | 299 | 299 | 300 |
Shares Change | -0.94% | -2.02% | - | 0.06% | -0.25% | -0.02% |
EPS (Basic) | 1.27 | 1.01 | 1.65 | 1.40 | 3.44 | 3.37 |
EPS (Diluted) | 1.27 | 1.01 | 1.65 | 1.40 | 3.44 | 3.37 |
EPS Growth | -2.30% | -38.91% | 17.48% | -59.25% | 1.96% | 145.38% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 300.24 | 409.43 | -77.99 | 190.74 | 571.54 | 527.23 |
Free Cash Flow Per Share | 1.02 | 1.40 | -0.26 | 0.64 | 1.91 | 1.76 |
Dividend Per Share | 0.800 | 0.600 | 0.700 | 1.200 | 2.500 | 2.700 |
Dividend Growth | 23.08% | -14.29% | -41.67% | -52.00% | -7.41% | 170.00% |
Gross Margin | 26.70% | 25.18% | 31.37% | 31.90% | 45.52% | 46.40% |
Operating Margin | 13.75% | 13.73% | 18.89% | 22.53% | 38.30% | 40.56% |
Profit Margin | 12.59% | 10.65% | 17.83% | 17.67% | 30.35% | 32.21% |
Free Cash Flow Margin | 10.16% | 14.78% | -2.82% | 8.03% | 16.85% | 16.78% |
EBITDA | 583.5 | 563.43 | 678.2 | 680.72 | 1,463 | 1,434 |
EBITDA Margin | 19.74% | 20.34% | 24.53% | 28.66% | 43.12% | 45.63% |
D&A For EBITDA | 177.08 | 183.13 | 155.96 | 145.47 | 163.59 | 159.33 |
EBIT | 406.42 | 380.3 | 522.25 | 535.25 | 1,299 | 1,274 |
EBIT Margin | 13.75% | 13.73% | 18.89% | 22.53% | 38.30% | 40.56% |
Effective Tax Rate | - | 12.04% | - | 19.89% | 19.84% | 20.05% |
Revenue as Reported | 2,960 | 2,773 | 2,776 | 2,393 | 3,407 | 3,145 |